Elevation Spine Closes $11 Million Financing

Elevation Spine Saber-C Spinal Fusion Implant

Elevation Spine completed its Series B Preferred Stock financing, totaling $11 million.

Proceeds will support increased commercial production of Saber-C® spinal fusion technology, as well as development of future product extensions of the company’s Saber Technology platform of products.

Charles Gilbride, CEO of Elevation Spine, said, “This...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us